Management of Auditory Hallucinations as a Sequela of Traumatic Brain Injury
| Autor: | Vikram K. Sundaram, Robert L. Barkin, Yuriy Dobry, Vladan Novakovic |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Male
Psychosis medicine.medical_specialty Hallucinations Traumatic brain injury MEDLINE Poison control PsycINFO Neuropsychological Tests law.invention Randomized controlled trial law Injury prevention Humans Medicine Pharmacology (medical) Psychiatry Psychiatric Status Rating Scales Pharmacology Behavior business.industry Sequela General Medicine Middle Aged medicine.disease Magnetic Resonance Imaging nervous system diseases Hospitalization Psychotherapy Psychotic Disorders Brain Injuries business |
| Zdroj: | American Journal of Therapeutics. 21:e1-e6 |
| ISSN: | 1075-2765 |
| DOI: | 10.1097/mjt.0b013e31825e3a80 |
| Popis: | A patient with progressively worsening auditory hallucinations and 30-year history of traumatic brain injury (TBI) was reported. To formulate a comprehensive diagnostic and treatment approach to patients with auditory sensory disturbances and other neuropsychiatric sequela of a TBI, an electronic search of the major behavioral science databases (PubMed, PsycINFO, Medline) and a textbook review were conducted to retrieve studies detailing the clinical characteristics, biological mechanisms, and therapeutic approaches to post-TBI psychosis. Additional references were incorporated from the bibliographies of the retrieved articles. Although infrequent, auditory hallucinations is a debilitating complication of TBI that can manifest itself 4-5 years after the occurrence of TBI. Because the age range of TBI survivors is 15-24 years, and the chance of developing post-TBI psychosis is reported to be up to 20%, this chronic neuropsychiatric complication and the available treatment options warrant close scrutiny from the clinical and the biomedical research community. Our case report and literature review demonstrates a clear need for a large, well-designed randomized trials to compare properties and efficacies of different, available, and promising pharmacotherapy agents for the treatment of post-TBI psychosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|